SOPHiA GENETICS Earnings Call Signals Strong Momentum
SOPHiA GENETICS (SOPH) reported Q3 revenue of $24.3M, up 25% YoY, with record analysis volumes and improved adjusted EBITDA loss of $6.1M. U.S. revenue grew 41%, and new customer wins were highlighted. Challenges include FX pressure and implementation delays.



